BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 9756642)

  • 1. Acceleration of experimental autoimmune encephalomyelitis in interleukin-10-deficient mice: roles of interleukin-10 in disease progression and recovery.
    Samoilova EB; Horton JL; Chen Y
    Cell Immunol; 1998 Sep; 188(2):118-24. PubMed ID: 9756642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells.
    Samoilova EB; Horton JL; Hilliard B; Liu TS; Chen Y
    J Immunol; 1998 Dec; 161(12):6480-6. PubMed ID: 9862671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice.
    Bettelli E; Das MP; Howard ED; Weiner HL; Sobel RA; Kuchroo VK
    J Immunol; 1998 Oct; 161(7):3299-306. PubMed ID: 9759845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental autoimmune encephalomyelitis in NF-kappa B-deficient mice:roles of NF-kappa B in the activation and differentiation of autoreactive T cells.
    Hilliard B; Samoilova EB; Liu TS; Rostami A; Chen Y
    J Immunol; 1999 Sep; 163(5):2937-43. PubMed ID: 10453042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A critical role for IL-4 in regulating disease severity in experimental allergic encephalomyelitis as demonstrated in IL-4-deficient C57BL/6 mice and BALB/c mice.
    Falcone M; Rajan AJ; Bloom BR; Brosnan CF
    J Immunol; 1998 May; 160(10):4822-30. PubMed ID: 9590229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do Th2 cells mediate the effects of glatiramer acetate in experimental autoimmune encephalomyelitis?
    Jee Y; Liu R; Bai XF; Campagnolo DI; Shi FD; Vollmer TL
    Int Immunol; 2006 Apr; 18(4):537-44. PubMed ID: 16481342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HSV-1-mediated IL-1 receptor antagonist gene therapy ameliorates MOG(35-55)-induced experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Furlan R; Bergami A; Brambilla E; Butti E; De Simoni MG; Campagnoli M; Marconi P; Comi G; Martino G
    Gene Ther; 2007 Jan; 14(1):93-8. PubMed ID: 16929354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmunity against myelin oligodendrocyte glycoprotein is dispensable for the initiation although essential for the progression of chronic encephalomyelitis in common marmosets.
    Jagessar SA; Smith PA; Blezer E; Delarasse C; Pham-Dinh D; Laman JD; Bauer J; Amor S; 't Hart B
    J Neuropathol Exp Neurol; 2008 Apr; 67(4):326-40. PubMed ID: 18379435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-10 mediates resistance to adoptive transfer experimental autoimmune encephalomyelitis in MyD88(-/-) mice.
    Cohen SJ; Cohen IR; Nussbaum G
    J Immunol; 2010 Jan; 184(1):212-21. PubMed ID: 19949074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmacytoid DC promote priming of autoimmune Th17 cells and EAE.
    Isaksson M; Ardesjö B; Rönnblom L; Kämpe O; Lassmann H; Eloranta ML; Lobell A
    Eur J Immunol; 2009 Oct; 39(10):2925-35. PubMed ID: 19637225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that Fas and FasL contribute to the pathogenesis of experimental autoimmune encephalomyelitis.
    Dittel BN
    Arch Immunol Ther Exp (Warsz); 2000; 48(5):381-8. PubMed ID: 11140465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylprednisolone induces reversible clinical and pathological remission and loss of lymphocyte reactivity to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis.
    Chan J; Ban EJ; Chun KH; Wang S; McQualter J; Bernard C; Toh BH; Alderuccio F
    Autoimmunity; 2008 Aug; 41(5):405-13. PubMed ID: 18568646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental autoimmune encephalomyelitis in intercellular adhesion molecule-1-deficient mice.
    Samoilova EB; Horton JL; Chen Y
    Cell Immunol; 1998 Nov; 190(1):83-9. PubMed ID: 9826450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization.
    Hjelmström P; Juedes AE; Fjell J; Ruddle NH
    J Immunol; 1998 Nov; 161(9):4480-3. PubMed ID: 9794370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
    Murphy AC; Lalor SJ; Lynch MA; Mills KH
    Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein.
    Lyons JA; Ramsbottom MJ; Cross AH
    Eur J Immunol; 2002 Jul; 32(7):1905-13. PubMed ID: 12115610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis.
    Kala M; Rhodes SN; Piao WH; Shi FD; Campagnolo DI; Vollmer TL
    Exp Neurol; 2010 Jan; 221(1):136-45. PubMed ID: 19879259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis.
    Marta M; Andersson A; Isaksson M; Kämpe O; Lobell A
    Eur J Immunol; 2008 Feb; 38(2):565-75. PubMed ID: 18203139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-6 plays a crucial role in the induction phase of myelin oligodendrocyte glucoprotein 35-55 induced experimental autoimmune encephalomyelitis.
    Okuda Y; Sakoda S; Fujimura H; Saeki Y; Kishimoto T; Yanagihara T
    J Neuroimmunol; 1999 Nov; 101(2):188-96. PubMed ID: 10580801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of MOG-stimulated Th1 type "light up" (GFP+) CD4+ T cells for the development of experimental autoimmune encephalomyelitis (EAE).
    Yura M; Takahashi I; Serada M; Koshio T; Nakagami K; Yuki Y; Kiyono H
    J Autoimmun; 2001 Aug; 17(1):17-25. PubMed ID: 11488634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.